Vixarelimab
id:
vixarelimab-268-14697533
title:
Vixarelimab
text:
Vixarelimab (KPL-716) is a fully human monoclonal antibody that works by binding to the oncostatin M receptor β, thus inhibiting both interleukin 31 and oncostatin M. It is developed by Kiniksa Pharmaceuticals for prurigo nodularis.
brand slug:
wiki
category slug:
encyclopedia
description:
original url:
https://en.wikipedia.org/wiki/Vixarelimab
date created:
date modified:
2024-04-17T23:23:00Z
main entity:
{"identifier":"Q123598888","url":"https://www.wikidata.org/entity/Q123598888"}
image:
fields total:
13
integrity:
13